Related Experiment Videos

Impaired bacterial killing and hydrogen peroxide production by polymorphonuclear neutrophils in end-stage renal

C J Porter1, R P Burden, A G Morgan

  • 1Department of Renal Medicine, Nottingham City Hospital NHS Trust, UK.

Nephron
|January 1, 1997
PubMed

Insights

Polymorphonuclear leukocytes (PMN) from conservatively treated end-stage renal failure (ESRF) patients show reduced intracellular hydrogen peroxide production. This impaired hydrogen peroxide activity likely explains their reduced ability to kill bacteria.

Area of Science:

  • Immunology
  • Nephrology
  • Biochemistry

Background:

  • End-stage renal failure (ESRF) is associated with impaired immune function.
  • Polymorphonuclear leukocytes (PMN) play a crucial role in bacterial killing.
  • A sub-population of ESRF patients exhibits defective intracellular bacterial killing by PMN.

Purpose of the Study:

  • To investigate the mechanism behind impaired intracellular bacterial killing in a subset of ESRF patients.
  • To compare hydrogen peroxide generation in PMN from conservatively treated ESRF patients, ESRF patients on continuous ambulatory peritoneal dialysis (CAPD), and healthy controls.

Main Methods:

  • Isolation of PMN from three groups: conservatively treated ESRF patients, CAPD-treated ESRF patients, and healthy volunteers.
  • Assay of hydrogen peroxide activity using two techniques to differentiate total and intracellular generation.
  • Quantification of intracellular hydrogen peroxide production via fluorescence units.

Main Results:

  • PMN from conservatively treated ESRF patients showed significantly reduced intracellular hydrogen peroxide production (37.7 ± 4.3 FU).
  • PMN from CAPD-treated ESRF patients (57.9 ± 6.6 FU) and healthy controls (60.4 ± 3.5 FU) exhibited comparable and higher levels of intracellular hydrogen peroxide production.
  • A clear distinction in hydrogen peroxide generation was observed between conservatively treated ESRF patients and the other two groups.

Conclusions:

  • The impaired intracellular bacterial killing observed in PMN from conservatively treated ESRF patients is likely due to reduced intracellular hydrogen peroxide production.
  • Conservative management of ESRF may negatively impact PMN's oxidative burst capacity.
  • Further research is warranted to explore therapeutic strategies to enhance PMN function in ESRF patients.

Related Concept Videos